Tumor necrosis factor (TNF) mediates a wide variety of disease states including septic shock, acute and chronic inflammation, and cachexia. Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production and protect against tissue inflammation and endotoxin
macrophages activated by 15 min of LPS stimulation, indicating that CNI-1493 does not interfere with early NF-KBmediated transcriptional regulation of TNF. However, synthesis of the 26-kDa membrane form of TNF was effectively blocked by CNI-1493 . Further evidence for the translational suppression of TNF is given by experiments using chloramphenicol acetyltransferase (CAT) constructs containing elements of the TNF gene that are involved in TNF translational regulation. Both the 5' and 3' untranslated regions of the TNF gene were required to elicit maximal translational suppression by CNI-1493 . Identification of the molecular target through which CNI-1493 inhibits TNF translation should provide insight into the regulation of macrophage activation and mechanisms of inflammation.
Following the activation of monocytes and macrophages, the rapid production of proinflammatory cytokines [such as tumor necrosis factor (TNF), interleukins 1 and 6 (IL-1 and IL-6) and others] mediates a wide variety of pathologic states, including lethal shock and tissue injury, acute and chronic inflammation, and cachexia (1) . We recently described a tetravalent guanylhydrazone compound (CNI-1493) that suppressed lipopolysaccharide (LPS)-stimulated macrophage synthesis of proinflammatory cytokines [TNF, IL-1, IL-6, macrophage inflammatory proteins la and 1,3 (MIP-la and MIP-1l3], inhibited the synthesis of inducible nitric oxide synthase (iNOS), and protected against lethal endotoxemia and carrageenaninduced inflammation in mice (2, 3) . Previous evidence indicates that these macrophage-suppressive effects were selective. For (1) . This production is mediated by increases in the transcription and translation of the TNF gene (4) . Recent evidence suggests that discrete signal transduction pathways regulate the transcriptional and translational regulatory events (Fig. 1) . The p38 MAP kinase signal transduction pathway, whose intermediates include cdc42, MEKK, MKK3/MKK4, and p38 MAP kinase (5-7), has been implicated in the enhancement of TNF translation efficiency after LPS stimulation (8) (9) (10) . Transcriptional activation is mediated by pathways culminating in nuclear translocation of the transcriptional regulator NF-KB. In these cascades, LPS stimulates the release of I-KB from cytoplasmic NF-KB, resulting in translocation of NF-KB from the cytoplasm to the nucleus, where it binds KB consensus binding sites in the promoters of target genes including TNF and genes of other proinflammatory cytokines (11) (12) (13) . In the present investigation, we determine the mechanism by which CNI-1493 suppresses TNF protein synthesis. The (1996) lated with 100 ng of LPS per ml for 15 min. Cells were then rinsed in ice-cold PBS and harvested. Extracts were prepared essentially as described (16) and incubated with 32P-labeled oligodeoxynucleotides corresponding to the NF-KB consensus binding site (Promega). Binding reactions and electrophoresis were performed as described (16) .
TNF Pulse Labeling. Newly synthesized proteins were radiolabeled by using a modified version of previously described methods (17, 18) . Briefly (Fig. 2) . Addition of CNI-1493 in quantities that suppressed 95% of secreted TNF protein (1 /aM) in these experiments did not significantly reduce the increased expression of TNF mRNA (Fig. 2) . We observed a modest reduction in peak steady-state level of TNF mRNA, which was attributable to decreased TNF mRNA stability, measured by treating PBMCs with LPS and CNI-1493 in the presence of actinomycin D (Fig. 2) . Thus, these data give evidence that the suppressive effect of CNI-1493 on TNF protein production cannot be due to suppression of TNF mRNA expression.
CNI-1493 Does Not Inhibit Nuclear Translocation of NF-KB During Early Macrophage Activation. Because CNI-1493 did not interfere with LPS-induced up-regulation of TNF mRNA, these results predicted that CNI-1493 would not suppress the early activation of NF-KB, a transcriptional activator of TNF (13, 25, 26) . Accordingly, the electrophoretic mobility-shift assay was utilized to address this hypothesis. Addition of CNI-1493 at concentrations that inhibit 50% and 95% of TNF protein (0.5 and 1 ,M, respectively) did not inhibit the nuclear translocation of NF-KB following LPS stimulation (Fig. 3) (17) . CNI-1493 effectively suppressed the synthesis of the 26-kDa prohormone (Fig. 4) . Because the 26-kDa prohormone is the precursor to mature 17-kDa TNF, inhibition of 26-kDa protein translation thereby prevented appearance of the 17-kDa form as well (Fig. 4) contribute to the enhanced translational efficiency of TNF mRNA in monocytes/macrophages after LPS stimulation (19, 20, 27) . We used these same CAT plasmid constructs to address whether the suppressive effect of CNI-1493 on TNF protein translation depended on the presence of either or both of these elements. In agreement with previous work (19, 20, 27), transfection of RAW 264.7 cells with the 3' UTR,5' UTR, and 5' UTR-3' UTR construct suppressed expression of CAT as compared with transfections with CMV-CAT constructs not containing TNF elements (data not shown), and addition of LPS significantly stimulated CAT reporter activity (Fig. 5) . Addition of 1 ,uM CNI-1493 suppressed CAT reporter biosynthesis in LPS-treated cells containing either the 5' UTR, the 3' UTR, or the 5' UTR-3' UTR constructs (Fig. 5) . Average suppression of LPS-mediated CAT biosynthesis for the different constructs we observed was: 5' UTR (24 + 2%, n = 3), 3 ' UTR (24 + 17%, n = 3) and 5' UTR-3' UTR (74 ± 10%, n = 2). Expression of CAT in CMV-CAT control transfectants was detected under all conditions and was not responsive to the addition of either LPS or CNI-1493 (data not shown). Note that maximal suppression by CNI-1493 was observed only when both elements were present, suggesting that suppression of TNF (Fig. 3) and thereby enabled significant increases of TNF mRNA, as normally occurs after LPS stimulation (Fig. 2) . The translation inhibition was observed to be dependent upon both the 3' and 5' UTR elements of the TNF mRNA (Fig. 5) . We have previously shown that inhibition of TNF synthesis is specific, because total cellular synthesis of RNA and protein were unaffected by quantities of CNI-1493 that effectively suppress TNF synthesis (3).
Previous work suggests that after macrophage activation, discrete signaling pathways regulate the p38 MAP kinasedependent increases of TNF translation and the NF-KBdependent enhancement of TNF transcription (Fig. 1) . Raf IL-1, IL-6, MIP-la, MIP-1,3) , iNOS, and cytokine-inducible L-arginine transporter functions in LPSstimulated macrophages (2, 3) . It will be of interest to determine whether CNI-1493 suppressed these proinflammatory responses as an indirect consequence of TNF blockade or by a direct effect that suppressed a shared regulatory mechanism common to these proinflammatory mediators. CNI-1493 is also an effective macrophage cytokine suppressor in the presence of IFN-y, suggesting that it will retain its effectiveness in clinical conditions where IFN-y is ubiquitous (29). Because IFN-y can override the suppression of TNF in the C3H/HeJ mice, which normally fail to produce TNF in response to LPS, it will be of interest to use CNI-1493 to further characterize the molecular basis for this genetic defect (29, 30) . It is hoped that these studies will further understanding of the mechanism of macrophage activation and cytokine synthesis and lead to the development of therapeutic strategies to prevent the manifestation of macrophage-mediated disease.
